PlainRecalls
FDA Drug Moderate Class II Terminated

Lannett Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL Rx Only Distributed by: Lannett Company, Inc. Philadelphia, PA 19154 NDC 54838-550-80

Reported: November 20, 2019 Initiated: October 28, 2019 #D-0309-2020

Product Description

Lannett Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL Rx Only Distributed by: Lannett Company, Inc. Philadelphia, PA 19154 NDC 54838-550-80

Reason for Recall

CGMP Deviations: Presence of NDMA impurity detected in product.

Details

Recalling Firm
Lannett Company, Inc.
Units Affected
683,149 bottles
Distribution
Nationwide
Location
Philadelphia, PA

Frequently Asked Questions

What product was recalled?
Lannett Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL Rx Only Distributed by: Lannett Company, Inc. Philadelphia, PA 19154 NDC 54838-550-80. Recalled by Lannett Company, Inc.. Units affected: 683,149 bottles.
Why was this product recalled?
CGMP Deviations: Presence of NDMA impurity detected in product.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 20, 2019. Severity: Moderate. Recall number: D-0309-2020.